Merck Announces First-Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
April 25, 2024 6:47 AM EDTMerck (NYSE: MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked its outlook for the fiscal year 2024.
For Q1 2024, Merck reported earnings per share (EPS) at $2.07, surpassing analyst expectations of $1.93. The companys revenue for the quarter was $15.8 billion,... More



